Related Experiment Video

Updated: Apr 18, 2026

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

18.6K

Personalized prostate cancer therapy based on systems analysis of the apoptosis regulatory network

George Kulik1

  • 1Life Sciences Program, College of Science, Alfaisal University, Riyadh 11533, Saudi Arabia; Department of Cancer Biology, Wake Forest University Health Sciences, Winston Salem, NC 27157, USA, .

Asian Journal of Andrology
|January 13, 2015
PubMed

Insights

Advanced prostate cancer often becomes androgen-independent, requiring new therapeutic strategies. A systems approach analyzing apoptosis regulation can identify patients likely to respond to apoptosis-inhibiting drugs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Systems Biology

Background:

  • Advanced prostate cancer frequently progresses to an androgen-independent state, limiting treatment efficacy.
  • The complex signaling in androgen-independent prostate cancer presents therapeutic design challenges.
  • Apoptosis regulation is a critical factor in prostate cancer progression.

Purpose of the Study:

  • To explore a systems biology approach for understanding androgen-independent prostate cancer.
  • To identify potential therapeutic targets by analyzing apoptosis regulation.
  • To predict patient response to apoptosis-inhibiting therapies.

Main Methods:

  • Integrated analysis of antiapoptotic signaling network topology.
  • Characterization of signal transduction pathways inhibiting apoptosis.
  • Assessment of Bcl2 family protein expression in prostate cancer.

Main Results:

  • A systems approach integrating network topology, signaling pathways, and protein expression is valuable.
  • This approach can elucidate mechanisms of androgen-independent prostate cancer.
  • Potential for identifying patient subgroups responsive to specific treatments.

Conclusions:

  • A systems biology framework offers a promising strategy for tackling androgen-independent prostate cancer.
  • Understanding apoptosis regulation is key to developing targeted therapies.
  • Predictive biomarkers for apoptosis-targeted treatments can be identified through this integrated approach.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.1K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.3K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
856